Everest Organics Ltd

Net profit of Everest Organics rose 4750.00% to Rs 2.91 crore in the quarter ended March 2025 as against Rs 0.06 crore during the previous quarter ended March 2024. Sales declined 22.22% to Rs 40.93 crore in the quarter ended March 2025 as against Rs 52.62 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 1.29 crore in the year ended March 2025 as against net profit of Rs 0.14 crore during the previous year ended March 2024. Sales declined 19.14% to Rs 159.48 crore in the year ended March 2025 as against Rs 197.24 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales40.9352.62 -22 159.48197.24 -19 OPM %8.405.61 -4.535.57 - PBDT2.512.01 25 2.726.41 -58 PBT0.950.16 494 -3.240.61 PL NP2.910.06 4750 -1.290.14 PL Powered by Capital Market - Live

Everest Organics will hold a meeting of the Board of Directors of the Company on 27 May 2025.Powered by Capital Market - Live

The Rabeprazole Sodium API is primarily used to treat conditions related to excessive stomach acid production, including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, as it acts as a proton pump inhibitor (PPI) by significantly reducing the amount of acid produced in the stomach, essentially helping to heal ulcers and alleviate symptoms like heartburn and acid reflux. According to the regulatory filing, the company revealed that the approval, granted in February 2025, allows it to export its Rabeprazole Sodium API to the South Korean market. Everest Organics is engaged in the manufacturing of active pharmaceutical ingredients and bulk drugs. The company's standalone net profit surged to Rs 1.14 crore in Q3 FY25 as against Rs 0.02 crore posted in Q3 FY24. However, revenue from operations fell 19.9% YoY to Rs 42.05 crore in the quarter ended 31 December 2024. Powered by Capital Market - Live

Net profit of Everest Organics rose 5600.00% to Rs 1.14 crore in the quarter ended December 2024 as against Rs 0.02 crore during the previous quarter ended December 2023. Sales declined 19.92% to Rs 42.05 crore in the quarter ended December 2024 as against Rs 52.51 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales42.0552.51 -20 OPM %9.565.35 - PBDT2.621.49 76 PBT1.150.16 619 NP1.140.02 5600 Powered by Capital Market - Live

Everest Organics will hold a meeting of the Board of Directors of the Company on 11 February 2025.Powered by Capital Market - Live

Everest Organics will hold a meeting of the Board of Directors of the Company on 13 January 2025.Powered by Capital Market - Live

Everest Organics announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 8 January 2025.Powered by Capital Market - Live

The headline equity indices traded near flat line with negative bias in early afternoon trade. The Nifty traded below the 24,700 level after hitting day's high of 24,705 in early trade. Metal shares declined after advancing in past two consecutive trading sessions. At 12:26 IST, the barometer index, the S&P BSE Sensex was down 28.10 points or 0.03% to 81,681.02. The Nifty 50 index lost 11.15 points or 0.05% to 24,666.65. The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index rose 0.39% and the S&P BSE Small-Cap index rallied 0.54%. The market breadth was strong. On the BSE, 2,416 shares rose and 1,555 shares fell. A total of 169 shares were unchanged. Derivatives: The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, shed 0.17% to 14.12. The Nifty 26 December 2024 futures were trading at 24,736, at a premium of 69.35 points as compared with the spot at 24,666.65. The Nifty option chain for the 26 December 2024 expiry showed maximum Call OI of 49.6 lakh contracts at the 26,000 strike price. Maximum Put OI of 68.7 lakh contracts was seen at 24,000 strike price. Buzzing Index: The Nifty Metal index slipped 0.75% to 9,326.90. The index rallied 1.80% in past two consecutive trading sessions. Vedanta (down 2.23%), Hindalco Industries (down 2.01%), National Aluminium Company (down 0.72%), NMDC (down 0.67%), JSW Steel (down 0.64%), Hindustan Zinc (down 0.51%), Tata Steel (down 0.5%), Jindal Stainless (down 0.15%), Ratnamani Metals & Tubes (down 0.13%) and Jindal Steel & Power (down 0.12%) declined. On the other hand, Welspun Corp (up 1.67%), APL Apollo Tubes (up 1.23%) and Hindustan Copper (up 0.59%) edged higher. Stocks in Spotlight: Everest Organics hit an upper circuit of 20% after the after the company announced that its board of directors will meet on 10 December 2024 to consider and approve the proposal for fundraising and the appointment of an independent director. Power Finance Corporation rose 0.61%. The company's wholly owned subsidiary, PFC Consulting has incorporated a special purpose vehicle (SPV) company, NER Expansion Transmission the purpose of North-Eastern Region Expansion Scheme-XXV Part-A (NERES-XXV Part-A). One 97 Communications (Paytm) added 0.70%. The company informed that its wholly-owned subsidiary, One97 Communications Singapore (Paytm Singapore), has approved sale of stock acquisition rights (SARs) held in PayPay Corporation, Japan (PayPay) for Rs 2,364 crore.Powered by Capital Market - Live

According to the regulatory filing, the board will discuss and approve a proposal to raise funds through the preferential allotment of equity shares or other securities, subject to necessary approvals, including those from shareholders and regulatory authorities. Additionally, the board will consider the appointment of Narayana Rao as an Independent Director of the company. The official announcement was made on Saturday, 07 December 2024. The company is engaged in manufacturing of Active Pharmaceutical Ingredients and their intermediaries. The company commenced its commercial operations in the year 1993. It set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations. It came out with a public issue in Jan.'95 to part-finance the project. The company's standalone net profit surged to Rs 74 lakh in Q2 FY25 as against Rs 3 lakh posted in Q2 FY24. However revenue from operations fell 10.9% YoY to Rs 44.05 crore in the quarter ended 30 September 2024. As of 09 December 2024, the company's market capitalization stood at Rs 135.64 crore on the BSE. Powered by Capital Market - Live

Everest Organics will hold a meeting of the Board of Directors of the Company on 10 December 2024Powered by Capital Market - Live